Related Experiment Video
Updated: Aug 19, 2026

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
Abstract:
P. aeruginosa is widely distributed in nature and in the hospital environment with a predilection for moist areas. Its inherent resistance to many antimicrobials and its ability to produce many enzymes contribute to its pathogenic potential as both a primary and a secondary cause of infection. It is easily grown and identified in the microbiology laboratory. However, susceptibility testing remains a problem. Currently, the best approach to treatment is an aminoglycoside and an antipseudomonal beta-lactam antimicrobial. Typing can differentiate strains, but should be reserved for specific epidemiologic problems.
Insights
Pseudomonas aeruginosa (P. aeruginosa) is a common pathogen causing infections due to its antimicrobial resistance. Effective treatment involves specific antibiotic combinations, while strain typing is reserved for epidemiological investigations.
Area of Science:
- Microbiology
- Infectious Diseases
- Clinical Science
Background:
- Pseudomonas aeruginosa (P. aeruginosa) is ubiquitous in natural and hospital settings, often colonizing moist environments.
- This opportunistic pathogen possesses inherent antimicrobial resistance and enzymatic capabilities, contributing to its significant role in primary and secondary infections.
- While P. aeruginosa is readily cultured and identified in laboratories, determining its antimicrobial susceptibility presents challenges.
Purpose of the Study:
- To summarize the key characteristics of P. aeruginosa relevant to clinical practice.
- To highlight challenges in susceptibility testing.
- To provide guidance on current effective treatment strategies and strain typing applications.
Main Methods:
- Literature review of P. aeruginosa epidemiology, pathogenicity, and laboratory characteristics.
- Analysis of current antimicrobial susceptibility testing limitations.
- Evaluation of recommended therapeutic regimens and diagnostic typing methods.
Main Results:
- P. aeruginosa demonstrates widespread distribution and significant pathogenic potential.
- Susceptibility testing for P. aeruginosa remains a clinical challenge.
- Combined therapy with aminoglycosides and antipseudomonal beta-lactams is currently recommended.
- Strain differentiation is valuable for specific epidemiological investigations.
Conclusions:
- P. aeruginosa infections require careful management due to resistance.
- Optimal treatment relies on appropriate antimicrobial selection.
- Strain typing should be judiciously applied for targeted epidemiological studies.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Bacterial Phylum Actinobacteria
Atypical Pneumonia
Mechanism of Antibiotic Resistance in MRSA
Pneumonia I: Introduction

